Clinical Trials Directory

Trials / Completed

CompletedNCT03573843

Software-guided Cognitive Stimulation to Prevents Delirium

Cognitive Stimulation Guided by a Software to Prevent Delirium in Older Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of Chile · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

This study is a pilot randomized controlled trial, comparing a group of older patients with standardized non-pharmacological delirium prevention plus a basic tablet versus a group with standardized non-pharmacological delirium prevention plus a tablet with a software of cognitive stimulation (PREVEDEL). Software:It is a local development, including a interprofessional team of delirium healthcare experts, older patients and a team og engineers. The software was developed during the first year of this project and was inscribed for author rights. Inclusion criteria: Older patients \> 65 y.o. Admitted to medicine room or intermediate care unit \> 48 hrs, and informed consent to participate. Exclusion Criteria:Delirium positive, neuroleptic use, dementia, and non-spanish speakers. The study was approved by ethical committee of Hospital Clinico University of Chile Standardized Non-pharmacological intervention: Health workers were previously educated in delirium, and environmental issues were implemented. This intervention coverage in nine different domains: orientation, early mobilization, environmental noise and light, sensorial deficit, sleep, hydratation, drug reduction, and family participation. Intervention: All patients will have a tablet with or without the software PREVEDEL between 09:00-19:00 hrs. Measures: delirium will be monitoring with CAM (Confusion Assessment Method) twice a day for 5 days. Primary outcome: Delirium rate between both groups Secondary outcomes:Long of stay, severity od delirium, time of use of electronic device, and Barthel to discharge.

Conditions

Interventions

TypeNameDescription
OTHERPrevention softwareAll patients will have a tablet with the software PREVEDEL between 09:00-19:00 hrs.
OTHERPlaceboAll patients will have a tablet without the software PREVEDEL between 09:00-19:00 hrs.

Timeline

Start date
2018-06-15
Primary completion
2018-08-31
Completion
2019-10-30
First posted
2018-06-29
Last updated
2020-01-14

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT03573843. Inclusion in this directory is not an endorsement.